loading
Overview News Price History Financials Why RNAZ Down? Discussions Forecast Stock Split

Why is Transcode Therapeutics Inc (RNAZ) Stock down?

We've noticed a 37.93% decline in Transcode Therapeutics Inc (RNAZ) stock during the 2024-12-18 trading session. While this could be attributed to normal volatility or various internal and external factors, please be aware that we are actively monitoring the situation, and we'll provide timely updates as soon as possible!
26 Sep, 2023:

TransCode Therapeutics, Inc. (RNAZ) shares dropped 72.91% after the company priced its $8 million public offering of 15.7 million shares at $0.51 per share.

https://www.benzinga.com/news/earnings/23/09/34916592/crude-oil-moves-higher-cintas-earnings-top-estimates

Similar to RNAZ

biotechnology SMMT
$17.87
price down icon 2.88%
biotechnology INCY
$68.84
price up icon 2.65%
biotechnology MRNA
$39.39
price down icon 0.43%
biotechnology UTHR
$359.58
price down icon 0.16%
biotechnology BGNE
$176.50
price up icon 1.02%
biotechnology BNTX
$113.08
price up icon 1.56%
Open in Yahoo | Open in Google | Open in Finviz | Open in MarketWatch | Open in EDGAR | Open in Reuters
Cap:     |  Volume (24h):